Over 75% of health plans and over 50% of employers are moderately or very concerned about off-label use of GLP-1s approved for type 2 diabetes, but awareness of how much current spend is off-label is notably lower: nearly half of employers and a quarter of health plans are unsure
View image online ( 22-HVI-3411464_GLP-1-and-GIP-dual-agonism_650x450 Researchers and clinicians have long recognized a web of cause-and-effect relationships within the triad of cardiovascular disease (CVD), diabetes and obesity
Key Feature: Non-GMO &...
The article says this class is most appropriate for adults with a BMI of 27 or above who have a weight-related comorbidity, a BMI of 30 or above without one, or type 2 diabetes
Digestive Discomfort: You might experience increased bloating, gas, or sulfur burps as the medication slows gastric emptying (the speed at which food leaves your stomach)
With the hepatitis B virus immunohistochemistry can be used to identify infected hepatocytes reliably, but we do not have a clear picture of the number of HCV-infected hepatocytes in the liver or the characteristics of an HCV-infected cell